Screening compound: DXNIZIOBXRVTGK-QGZVFWFLSA-N

Screening compound: DXNIZIOBXRVTGK-QGZVFWFLSA-N
Screening compound: DXNIZIOBXRVTGK-QGZVFWFLSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
DXNIZIOBXRVTGK-QGZVFWFLSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M976-0704

Molecular Formula

C22H27N3O3 (C22 H27 N3 O3)

Compound Name

1-(1-cyclobutanecarbonyl-2,3-dihydro-1H-indol-5-yl)-N-(cyclopropylmethyl)-5-oxopyrrolidine-3-carboxamide

IUPAC name

1-(1-cyclobutanecarbonyl-23-dihydro-1H-indol-5-yl)-N-(cyclopropylmethyl)-5-oxopyrrolidine-3-carboxamide

SMILES

O=C(C1CCC1)N(CC1)c(cc2)c1cc2N(CC(C1)C(NCC2CC2)=O)C1=O

InChI

InChI=1S/C22H27N3O3/c26-20-11-17(21(27)23-12-14-4-5-14)13-25(20)18-6-7-19-16(10-18)8-9-24(19)22(28)15-2-1-3-15/h6-7,10,14-15,17H,1-5,8-9,11-13H2,(H,23,27)/t17-/m1/s1

InChI Key

DXNIZIOBXRVTGK-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD27558436

DXNIZIOBXRVTGK-QGZVFWFLSA-N in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS MPO Library (28609 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Targets:
  • GPCR
  • Kinases

References: we are preparing a list of scientific research reports with DXNIZIOBXRVTGK-QGZVFWFLSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound DXNIZIOBXRVTGK-QGZVFWFLSA-N?
Check Price and Availability of DXNIZIOBXRVTGK-QGZVFWFLSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of DXNIZIOBXRVTGK-QGZVFWFLSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for DXNIZIOBXRVTGK-QGZVFWFLSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for DXNIZIOBXRVTGK-QGZVFWFLSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of DXNIZIOBXRVTGK-QGZVFWFLSA-N available by request